238 related articles for article (PubMed ID: 24243709)
1. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1.
Dai W; Wang F; He L; Lin C; Wu S; Chen P; Zhang Y; Shen M; Wu D; Wang C; Lu J; Zhou Y; Xu X; Xu L; Guo C
Mol Carcinog; 2015 Apr; 54(4):301-11. PubMed ID: 24243709
[TBL] [Abstract][Full Text] [Related]
2. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
[TBL] [Abstract][Full Text] [Related]
3. The anti-metastatic effect of 8-MOP on hepatocellular carcinoma is potentiated by the down-regulation of bHLH transcription factor DEC1.
Xiong J; Yang H; Luo W; Shan E; Liu J; Zhang F; Xi T; Yang J
Pharmacol Res; 2016 Mar; 105():121-33. PubMed ID: 26808085
[TBL] [Abstract][Full Text] [Related]
4. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
Kim YS; Choi KC; Hwang KA
Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro.
Cui J; Gong M; He Y; Li Q; He T; Bi Y
Int J Oncol; 2016 Jan; 48(1):349-57. PubMed ID: 26548461
[TBL] [Abstract][Full Text] [Related]
8. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
9. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
Yin W; Xu J; Li C; Dai X; Wu T; Wen J
Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
[TBL] [Abstract][Full Text] [Related]
10. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC
Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449
[TBL] [Abstract][Full Text] [Related]
11. AQP5 promotes hepatocellular carcinoma metastasis via NF-κB-regulated epithelial-mesenchymal transition.
He Z; Dong W; Hu J; Ren X
Biochem Biophys Res Commun; 2017 Aug; 490(2):343-348. PubMed ID: 28619511
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
Dong S; Kong J; Kong F; Kong J; Gao J; Ji L; Pan B; Chen L; Zheng L; Sun W
BMC Cancer; 2015 Nov; 15():939. PubMed ID: 26620566
[TBL] [Abstract][Full Text] [Related]
13. Extracts of Celastrus Orbiculatus Inhibit Cancer Metastasis by Down-regulating Epithelial-Mesenchymal Transition in Hypoxia-Induced Human Hepatocellular Carcinoma Cells.
Qian YY; Shi YY; Lu SH; Yang T; Zhao XY; Yan Y; Li WY; Liu YQ
Chin J Integr Med; 2019 May; 25(5):334-341. PubMed ID: 30046956
[TBL] [Abstract][Full Text] [Related]
14. HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.
Ru NY; Wu J; Chen ZN; Bian H
Cell Biol Int; 2015 Jan; 39(1):44-51. PubMed ID: 25044444
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermia inhibits transforming growth factor beta-induced epithelial-mesenchymal transition (EMT) in HepG2 hepatocellular carcinoma cells.
Xu XM; Yuan GJ; Li QW; Shan SL; Jiang S
Hepatogastroenterology; 2012 Oct; 59(119):2059-63. PubMed ID: 22709823
[TBL] [Abstract][Full Text] [Related]
16. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
[TBL] [Abstract][Full Text] [Related]
17. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition.
Feng B; Zhu Y; Sun C; Su Z; Tang L; Li C; Zheng G
Int J Biol Macromol; 2019 Sep; 137():32-44. PubMed ID: 31252022
[TBL] [Abstract][Full Text] [Related]
18. Nemopilema nomurai jellyfish venom exerts an anti-metastatic effect by inhibiting Smad- and NF-κB-mediated epithelial-mesenchymal transition in HepG2 cells.
Lee H; Pyo MJ; Bae SK; Heo Y; Choudhary I; Hwang D; Yang H; Kim JH; Chae J; Han CH; Kang C; Yum S; Kim E
Sci Rep; 2018 Feb; 8(1):2808. PubMed ID: 29434219
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT.
Wei Y; Lv B; Xie J; Zhang Y; Lin Y; Wang S; Zhong J; Chen Y; Peng Y; Ma J
Drug Des Devel Ther; 2019; 13():2343-2355. PubMed ID: 31409969
[TBL] [Abstract][Full Text] [Related]
20. The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.
Jiang X; Wang J; Zhang K; Tang S; Ren C; Chen Y
Med Oncol; 2015 May; 32(5):141. PubMed ID: 25805567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]